New $60 blood test detects lung cancer with 93% sensitivity
Reported bySciTechDaily ↗·Sourced by Goodlede
A blood test measuring DNA methylation patterns identified 93.1% of stage 2-4 lung cancers and 90.3% specificity in a 103-person study at Tel Aviv University and collaborating medical centers, using simple fluorescent labeling and microarray technology rather than costly DNA sequencing.
The test was validated on a separate blinded group within the same 103-person study; larger prospective trials would be needed before clinical deployment.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at SciTechDaily
Read original story ↗More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede
General
At K Khel Government Middle School in Nagaland, students grow vegetables for their own school lunches
The Better India · Verified
Health
Targeted light therapy treats gum disease while sparing healthy bacteria
SciTechDaily · Verified
Equality
After accessibility complaint goes viral, Quebec city hall promises to address free parking for people with disabilities
CBC Health · Verified